about
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathmiR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options.Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics.Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart.The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells.Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells.Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia.The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes
P50
Q33558697-DB37D780-F416-4414-8606-FFB7D4365048Q35930211-05283EF3-46C8-4B12-9ED8-B5C57D503445Q36058142-997C15EB-7A29-4D56-942F-B02D75F91B72Q36892616-473A8E92-3636-40E9-8C20-5DD13F84F1C6Q37448441-26AB333D-DA3A-4026-9A82-AFBACD5CC7FFQ37868181-F03B3768-0C2A-44D5-BB0F-A029169CB934Q38036547-2B772613-F7EC-46EA-9E2D-A469E68956BAQ38156474-91BA42DC-03F3-445D-B1DB-E831CD04AD24Q38956435-152A11E1-894D-404F-AD3D-AA8ECAF2D3DAQ39930338-F65D3B72-5246-42D6-B78B-C3BFC1B60E33Q40027775-5442318B-EEB6-4B1F-991F-865C7305FEB9Q41698622-85C790DB-D9BF-4728-8EDE-849CFFDD8115Q41769298-83AF1727-B321-42D1-BF45-E80FB14FE8D7Q42914143-C96217CA-AE40-4736-BDBC-6665BBB7D7E0Q43859473-FE7FAE22-FE4E-4FCD-B653-BE4123D09A73Q44140099-3B999CB2-ADC2-41CC-892E-6E2756D6085DQ46416340-82CA65D5-2776-42A4-848C-4BD17FF6B5BBQ51686376-C776CEDB-7BA6-4CD9-BCF9-0580D2EEB329Q53014079-963387A5-A687-4BA7-8516-42E39662E41DQ84974867-1494CB71-3232-4A99-8A79-73EFEE799B9B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Davide Brusa
@ast
Davide Brusa
@en
Davide Brusa
@es
Davide Brusa
@nl
type
label
Davide Brusa
@ast
Davide Brusa
@en
Davide Brusa
@es
Davide Brusa
@nl
prefLabel
Davide Brusa
@ast
Davide Brusa
@en
Davide Brusa
@es
Davide Brusa
@nl
P106
P31
P496
0000-0002-6499-9648